Facile conversion of racemic ibuprofen to (S)-ibuprofen

被引:19
|
作者
Chavez-Flores, David [1 ]
Salvador, James M. [1 ]
机构
[1] Univ Texas El Paso, Dept Chem, El Paso, TX 79968 USA
关键词
D O I
10.1016/j.tetasy.2012.02.014
中图分类号
O61 [无机化学];
学科分类号
070301 ; 081704 ;
摘要
The methyl ester of ibuprofen was quantitatively formed by Fischer esterification and converted into (S)-ibuprofen in 94% yield with an ee of 94% under dynamic kinetic resolution conditions at pH 9.8, using Candida rugosa lipase, and 20% DMSO. The (R)-methyl ibuprofen ester was observed to racemize by chiral HPLC without the Candida rugosa lipase present. The rates of in situ racemization and enzymatic hydrolysis for the dynamic kinetic resolution were determined to be 0.026 +/- 0.004 and 0.053 +/- 0.004 h(-1), respectively. The rate of enzymatic hydrolysis when no DMSO was present was twice as fast but no racemization occurred. A facile purification of enriched (S)-ibuprofen was developed. Overall, 88% of racemic ibuprofen by weight was converted into (S)-ibuprofen with an ee of 99.7%. (C) 2012 Elsevier Ltd. All rights reserved.
引用
收藏
页码:237 / 239
页数:3
相关论文
共 50 条
  • [41] Racemic species-of sodium ibuprofen: Characterization and polymorphic relationships
    Zhang, GGZ
    Paspal, SYL
    Suryanarayanan, R
    Grant, DJW
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2003, 92 (07) : 1356 - 1366
  • [42] COMPARISON OF THE BIOAVAILABILITY OF DEXIBUPROFEN ADMINISTERED ALONE OR AS PART OF RACEMIC IBUPROFEN
    GABARD, B
    NIRNBERGER, G
    SCHIEL, H
    MASCHER, H
    KIKUTA, C
    MAYER, JM
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1995, 48 (06) : 505 - 511
  • [43] Evaluation of the efficacy and dose-response relationship of dexibuprofen (S(+)-ibuprofen) in patients with osteoarthritis of the hip and comparison with racemic ibuprofen using the WOMAC osteoarthritis index
    Singer, F
    Mayrhofer, F
    Klein, G
    Hawel, R
    Kollenz, CJ
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2000, 38 (01) : 15 - 24
  • [44] Chiral resolution of racemic ibuprofen ester in an enzymatic membrane reactor
    Long, WS
    Kamaruddin, A
    Bhatia, S
    JOURNAL OF MEMBRANE SCIENCE, 2005, 247 (1-2) : 185 - 200
  • [45] Kinetics of lipase catalyzed enantioselective esterification of racemic ibuprofen in isooctane
    Xie, YC
    Liu, HZ
    Chen, JY
    CHINESE JOURNAL OF CHEMICAL ENGINEERING, 2000, 8 (01) : 6 - 14
  • [46] EFFECT OF RACEMIC IBUPROFEN DOSE ON THE MAGNITUDE AND DURATION OF PLATELET CYCLOOXYGENASE INHIBITION - RELATIONSHIP BETWEEN INHIBITION OF THROMBOXANE PRODUCTION AND THE PLASMA UNBOUND CONCENTRATION OF S(+)-IBUPROFEN
    EVANS, AM
    NATION, RL
    SANSOM, LN
    BOCHNER, F
    SOMOGYI, AA
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1991, 31 (02) : 131 - 138
  • [47] ACTIVITY OF IBUPROFEN RACEMATE AND S-IBUPROFEN IN A CUTANEOUS MODEL OF INFLAMMATION
    GABARD, B
    BIELI, E
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1990, 183 (06) : 2258 - 2259
  • [48] A COMPARISON OF IBUPROFEN AND IBUPROFEN LYSINATE
    GEISSINGER, G
    DIETZEL, K
    BRUNE, K
    ARCHIV DER PHARMAZIE, 1987, 320 (09) : 990 - 990
  • [49] PHARMACOKINETICS OF S(+)-IBUPROFEN AND R(-)-IBUPROFEN IN VOLUNTEERS AND 1ST CLINICAL-EXPERIENCE OF S(+)-IBUPROFEN IN RHEUMATOID-ARTHRITIS
    GEISSLINGER, G
    SCHUSTER, O
    STOCK, KP
    LOEW, D
    BACH, GL
    BRUNE, K
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1990, 38 (05) : 493 - 497
  • [50] Bioequivalence risk assessment of oral formulations containing racemic ibuprofen through a chiral physiologically based pharmacokinetic model of ibuprofen enantiomers
    Reig-Lopez, Javier
    Cuquerella-Gilabert, Marina
    Bandin-Vilar, Enrique
    Merino-Sanjuan, Matilde
    Mangas-Sanjuan, Victor
    Garcia-Arieta, Alfredo
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2024, 199